Logo Logo
Switch Language to German

Lucke, Tanja; Herrera, Ronald; Wacker, Margarethe; Holle, Rolf; Biertz, Frank; Nowak, Dennis ORCID logoORCID: https://orcid.org/0000-0001-7871-8686; Huber, Rudolf M.; Söhler, Sandra; Vogelmeier, Claus; Ficker, Joachim H.; Mückter, Harald and Jörres, Rudolf A. ORCID logoORCID: https://orcid.org/0000-0002-9782-1117 (2016): Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication.
In: PLOS ONE 11(10) [PDF, 1MB]

[thumbnail of 10.1371_journal.pone.0163408.pdf]

Download (1MB)


Objective In large cohort studies comorbidities are usually self- reported by the patients. This way to collect health information only represents conditions known, memorized and openly reported by the patients. Several studies addressed the relationship between self- reported comorbidities and medical records or pharmacy data, but none of them provided a structured, documented method of evaluation. We thus developed a detailed procedure to compare self- reported comorbidities with information on comorbidities derived from medication inspection. This was applied to the data of the German COPD cohort COSYCONET. Methods Approach I was based solely on ICD10-Codes for the diseases and the indications of medications. To overcome the limitations due to potential non-specificity of medications, Approach II was developed using more detailed information, such as ATC-Codes specific for one disease. The relationship between reported comorbidities and medication was expressed by a four-level concordance score. Results Approaches I and II demonstrated that the patterns of concordance scores markedly differed between comorbidities in the COSYCONET data. On average, Approach I resulted in more than 50% concordance of all reported diseases to at least one medication. The more specific Approach II showed larger differences in the matching with medications, due to large differences in the disease-specificity of drugs. The highest concordance was achieved for diabetes and three combined cardiovascular disorders, while it was substantial for dyslipidemia and hyperuricemia, and low for asthma. Conclusion Both approaches represent feasible strategies to confirm self-reported diagnoses via medication. Approach I covers a broad spectrum of diseases and medications but is limited regarding disease-specificity. Approach II uses the information from medications specific for a single disease and therefore can reach higher concordance scores. The strategies described in a detailed and reproducible manner are generally applicable in large studies and might be useful to extract as much information as possible from the available data.

Actions (login required)

View Item View Item